Application of Exosomes-Derived Mesenchymal Stem Cells in Treatment of Fungal Diseases: From Basic to Clinical Sciences

Fungal diseases such as candidiasis are some of the deadliest diseases among immunocompromised patients. These fungi naturally exist on human skin and throughout the digestive system. When the microbiota balance becomes upset, these fungi become pathogenic and potentially lethal. At the pathogenesis...

Full description

Bibliographic Details
Main Author: Seyedeh Ommolbanin Ghasemian
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Fungal Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/ffunb.2021.736093/full
id doaj-236981de301a4ac4bc495c4c48de1c04
record_format Article
spelling doaj-236981de301a4ac4bc495c4c48de1c042021-09-30T06:32:49ZengFrontiers Media S.A.Frontiers in Fungal Biology2673-61282021-09-01210.3389/ffunb.2021.736093736093Application of Exosomes-Derived Mesenchymal Stem Cells in Treatment of Fungal Diseases: From Basic to Clinical SciencesSeyedeh Ommolbanin GhasemianFungal diseases such as candidiasis are some of the deadliest diseases among immunocompromised patients. These fungi naturally exist on human skin and throughout the digestive system. When the microbiota balance becomes upset, these fungi become pathogenic and potentially lethal. At the pathogenesis of fungal diseases, host immune system response is diverse. At the early stages of fungal pathogenesis such as Candida albicans, it was shown that these fungi use the immune cells of the host body and cause malfunction the early induction of proinflammatory cytokines of the host body leading to a reduction in their numbers. However, at some stages of fungal diseases, the immune response is severe. Despite many treatments already being available, it seems that one of the best treatments could be an immune-stimulatory agent. Some of the subsets of MSCs and exosome-derived cells, as a cell-to-cell communicator agent, have many roles in the human body, including anti-inflammatory and immune-modulatory effects. However, the TLR4-primed and IL-17+ subsets of MSCs have been shown to have immune-stimulatory effects. These subsets of the MSCs produce pro-inflammatory cytokines and reduce immunosuppressive cytokines and chemokines. Thus, they could trigger inflammation and stop fungal pathogenesis. As some biological activities and molecules inherit elements of their exosomes from their maternal cells, the exosome-derived TLR4-primed and IL-17+ subsets of MSCs could be a good candidate for fighting against fungal diseases. The applications of exosomes in human diseases are well-known and expanding. It is time to investigate the exosomes application in fungal diseases. In this review, the probable role of exosomes in treating fungal diseases is explored.https://www.frontiersin.org/articles/10.3389/ffunb.2021.736093/fullfungiexosomemesenchymal stem cellinterleukin-17toll-like receptor 4
collection DOAJ
language English
format Article
sources DOAJ
author Seyedeh Ommolbanin Ghasemian
spellingShingle Seyedeh Ommolbanin Ghasemian
Application of Exosomes-Derived Mesenchymal Stem Cells in Treatment of Fungal Diseases: From Basic to Clinical Sciences
Frontiers in Fungal Biology
fungi
exosome
mesenchymal stem cell
interleukin-17
toll-like receptor 4
author_facet Seyedeh Ommolbanin Ghasemian
author_sort Seyedeh Ommolbanin Ghasemian
title Application of Exosomes-Derived Mesenchymal Stem Cells in Treatment of Fungal Diseases: From Basic to Clinical Sciences
title_short Application of Exosomes-Derived Mesenchymal Stem Cells in Treatment of Fungal Diseases: From Basic to Clinical Sciences
title_full Application of Exosomes-Derived Mesenchymal Stem Cells in Treatment of Fungal Diseases: From Basic to Clinical Sciences
title_fullStr Application of Exosomes-Derived Mesenchymal Stem Cells in Treatment of Fungal Diseases: From Basic to Clinical Sciences
title_full_unstemmed Application of Exosomes-Derived Mesenchymal Stem Cells in Treatment of Fungal Diseases: From Basic to Clinical Sciences
title_sort application of exosomes-derived mesenchymal stem cells in treatment of fungal diseases: from basic to clinical sciences
publisher Frontiers Media S.A.
series Frontiers in Fungal Biology
issn 2673-6128
publishDate 2021-09-01
description Fungal diseases such as candidiasis are some of the deadliest diseases among immunocompromised patients. These fungi naturally exist on human skin and throughout the digestive system. When the microbiota balance becomes upset, these fungi become pathogenic and potentially lethal. At the pathogenesis of fungal diseases, host immune system response is diverse. At the early stages of fungal pathogenesis such as Candida albicans, it was shown that these fungi use the immune cells of the host body and cause malfunction the early induction of proinflammatory cytokines of the host body leading to a reduction in their numbers. However, at some stages of fungal diseases, the immune response is severe. Despite many treatments already being available, it seems that one of the best treatments could be an immune-stimulatory agent. Some of the subsets of MSCs and exosome-derived cells, as a cell-to-cell communicator agent, have many roles in the human body, including anti-inflammatory and immune-modulatory effects. However, the TLR4-primed and IL-17+ subsets of MSCs have been shown to have immune-stimulatory effects. These subsets of the MSCs produce pro-inflammatory cytokines and reduce immunosuppressive cytokines and chemokines. Thus, they could trigger inflammation and stop fungal pathogenesis. As some biological activities and molecules inherit elements of their exosomes from their maternal cells, the exosome-derived TLR4-primed and IL-17+ subsets of MSCs could be a good candidate for fighting against fungal diseases. The applications of exosomes in human diseases are well-known and expanding. It is time to investigate the exosomes application in fungal diseases. In this review, the probable role of exosomes in treating fungal diseases is explored.
topic fungi
exosome
mesenchymal stem cell
interleukin-17
toll-like receptor 4
url https://www.frontiersin.org/articles/10.3389/ffunb.2021.736093/full
work_keys_str_mv AT seyedehommolbaninghasemian applicationofexosomesderivedmesenchymalstemcellsintreatmentoffungaldiseasesfrombasictoclinicalsciences
_version_ 1716863844637212672